EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Marine Pharmacology in 2019–2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action

Alejandro M S Mayer iD, Veronica A Mayer, Michelle Swanson-Mungerson iD, Marsha L Pierce iD, Abimael D Rodríguez, Fumiaki Nakamura iD, Orazio Taglialatela-Scafati iD

Marine Drugs · 2024

DOI: 10.3390/md22070309 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Marine Drugs, 2024. Verfasst von Alejandro M S Mayer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Graduate Studies, Midwestern University, 555 31st Street, Downers Grove, IL 60515, USA. Hauptthemen laut MEDLINE: Aquatic Organisms, Anti-Inflammatory Agents, Hypoglycemic Agents, Biological Products. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 372 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH-SC1 Award (Grant 1SC1GM086271-01A1) of the University of Puerto Rico to ADR, Midwestern University to A.M.S.M. NIH-SC1 Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current 2019–2021 marine pharmacology literature review provides a continuation of previous reviews covering the period 1998 to 2018. Preclinical marine pharmacology research during 2019–2021 was published by researchers in 42 countries and contributed novel mechanism-of-action pharmacology for 171 structurally characterized marine compounds. The peer-reviewed marine natural product pharmacology literature reported antibacterial, antifungal, antiprotozoal, antituberculosis, and antiviral mechanism-of-action studies for 49 compounds, 87 compounds with antidiabetic and anti-inflammatory activities that also affected the immune and nervous system, while another group of 51 compounds demonstrated novel miscellaneous mechanisms of action, which upon further investigation, may contribute to several pharmacological classes. Thus, in 2019–2021, a very active preclinical marine natural product pharmacology pipeline provided novel mechanisms of action as well as new lead chemistry for the clinical marine pharmaceutical pipeline targeting the therapy of several disease categories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aquatic OrganismsAnti-Inflammatory AgentsHypoglycemic AgentsBiological ProductsAntiviral AgentsAntitubercular AgentsHumansAnimalsNervous SystemImmune SystemAntifungal AgentsAntiprotozoal AgentsAnti-Bacterial Agents

Stichwörter der Autor:innen

drugmarinemechanismpharmaceuticalpharmacologypipelinepreclinicalreviewseatoxicology

Substanzen

Anti-Inflammatory AgentsHypoglycemic AgentsBiological ProductsAntiviral AgentsAntitubercular AgentsAntifungal AgentsAntiprotozoal AgentsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacology, College of Graduate Studies, Midwestern University, 555 31st Street, Downers Grove, IL 60515, USA.
  • Department of Nursing Education, School of Nursing, Aurora University, 347 S. Gladstone Ave., Aurora, IL 60506, USA.
  • Department of Microbiology and Immunology, College of Graduate Studies, Midwestern University, 555 31st Street, Downers Grove, IL 60515, USA.
  • Molecular Sciences Research Center, University of Puerto Rico, 1390 Ponce de León Avenue, San Juan, PR 00926, USA.
  • Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku 169-8555, Tokyo, Japan.
  • Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, I-80131 Napoli, Italy.

ORCID-Profile: Alejandro M S Mayer, Michelle Swanson-Mungerson, Marsha L Pierce, Fumiaki Nakamura, Orazio Taglialatela-Scafati

Förderung

  • NIGMS NIH HHS
  • NIH-SC1 Award (Grant 1SC1GM086271-01A1) of the University of Puerto Rico to ADR
  • Midwestern University to A.M.S.M. NIH-SC1 Award
  • MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases

Zitieren

APA

Mayer, A. M. S., Mayer, V. A., Swanson-Mungerson, M., Pierce, M. L., Rodríguez, A. D., Nakamura, F., & Taglialatela-Scafati, O. (2024). Marine Pharmacology in 2019–2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action. Marine Drugs. https://doi.org/10.3390/md22070309

Vancouver

Mayer AMS, Mayer VA, Swanson-Mungerson M, Pierce ML, Rodríguez AD, Nakamura F, et al. Marine Pharmacology in 2019–2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action. Marine Drugs. 2024. doi:10.3390/md22070309

BibTeX
@article{Mayer2024,
  author = {Mayer, Alejandro M S and Mayer, Veronica A and Swanson-Mungerson, Michelle and Pierce, Marsha L and Rodríguez, Abimael D and Nakamura, Fumiaki and Taglialatela-Scafati, Orazio},
  title = {Marine Pharmacology in 2019–2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action},
  journal = {Marine Drugs},
  year = {2024},
  doi = {10.3390/md22070309}
}
Kostenlos starten →